BUDGET IMPACT ANALYSIS OF VIBEGRON FOR THE TREATMENT OF OVERACTIVE BLADDER IN THE UNITED STATES

被引：0
|
作者：
Nesheim, J. [1 ]
Chen, J., V [2 ]
Gahn, J. C. [2 ]
Mudd, P. [3 ]
机构：
[1] Urovant Sci, Irvine, CA USA
[2] Med Decis Modeling, Indianapolis, IN USA
[3] Urovant Sci, Durham, NC USA
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PUK5
引用
下载
收藏
页码：S234 / S235
页数：2
相关论文
共 50 条
  • [1] Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USA
    Chen, Jing Voon
    Gahn, James C.
    Nesheim, Jeffrey
    Mudd, Paul N., Jr.
    PHARMACOECONOMICS, 2022, 40 (10) : 979 - 988
  • [2] Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USA
    Jing Voon Chen
    James C. Gahn
    Jeffrey Nesheim
    Paul N. Mudd,
    PharmacoEconomics, 2022, 40 : 979 - 988
  • [3] COST EFFECTIVENESS OF VIBEGRON FOR THE TREATMENT OF OVERACTIVE BLADDER IN THE UNITED STATES
    Chen, J., V
    Klein, T. M.
    Mudd, P.
    VALUE IN HEALTH, 2021, 24 : S235 - S235
  • [4] Cost-effectiveness of vibegron for the treatment of overactive bladder in the United States
    Chen, Jing Voon
    Klein, Timothy M.
    Nesheim, Jeffrey
    Mudd, Paul N., Jr.
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 1092 - 1100
  • [5] Evaluating vibegron for the treatment of overactive bladder
    Rechberger, Tomasz
    Wrobel, Andrzej
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (01) : 9 - 17
  • [6] Vibegron for the treatment of overactive bladder: a comprehensive update
    Gleicher, Stephanie
    Sebesta, Elisabeth M.
    Reynolds, W. Stuart
    Dmochowski, Roger
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (13) : 1479 - 1484
  • [7] Re: Evaluating Vibegron for the Treatment of Overactive Bladder
    Wein, Alan J.
    JOURNAL OF UROLOGY, 2021, 206 (01): : 167 - 168
  • [8] Vibegron (Gemtesa) for Overactive Bladder
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1623): : 67 - 69
  • [9] An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder
    Frankel, Jeffrey
    Staskin, David
    Varano, Susann
    Kennelly, Michael J.
    Jankowich, Rachael A.
    Haag-Molkenteller, Cornelia
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2022, 18 : 171 - 182
  • [10] Vibegron: a β3-adrenergic agonist for the treatment of overactive bladder
    Paton, D. M.
    DRUGS OF TODAY, 2021, 57 (08) : 507 - 517
12345